StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$232.23−4.75 (-2.00%)

Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –

Danaher Beckman Coulter (Diagnostics & Life Sciences) by Year

Beckman Coulter (Diagnostics & Life Sciences) — FDA 510(k) Clearances

QuarterlyAnnualMonthly

Danaher Beckman Coulter (Diagnostics & Life Sciences): 10 in FY2025, down 47.4% from a year earlier.

Latest, FY2025
10
Period ended Dec 31, 2025
Change on a year earlier
-47.4%
19 in FY2024
History
11 years
Since FY2015
Sources
1
U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE)

Where the FY2025 figure comes from

Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Reported in U.S. FDA openFDA Device 510(k) Clearances API.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBeckman Coulter (Diagnostics & Life Sciences) — FDA 510(k) ClearancesYear on yearSource
FY2025Dec 31, 202510-47.4%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2024Dec 31, 202419+18.8%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2023Dec 31, 202316+300.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2022Dec 31, 20224+100.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2021Dec 31, 20212-66.7%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2020Dec 31, 20206-40.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2019Dec 31, 201910+400.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2018Dec 31, 20182-77.8%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2017Dec 31, 20179+125.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2016Dec 31, 20164+33.3%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
FY2015Dec 31, 20153–U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Cite this data

StockData. (2026). Danaher Beckman Coulter (Diagnostics & Life Sciences), annual FY2015–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-510k-beckman-coulter

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.